Revenue growth is strong (+26% YoY) and the CHOPIN publication is a positive clinical catalyst, but the GAAP net income swing to a loss and declining adjusted EBITDA are headwinds. Monitor the Q2 2026 report for evidence that the Lancet publication is converting into accelerating procedure volume and margin improvement.
DCTH drugs
DCTH drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 7 $11.24entry
- T+1 · 6mo ago +2.14%α +1.31% · $11.48
- T+5 · 6mo ago +3.29%α +1.79% · $11.61
- T+20 · 6mo ago −8.10%α −11.23% · $10.33
- T+60 · 4mo ago +16.01%α +12.18% · $13.04
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Delcath Systems reported Q1 2026 revenue of $25.0M (+26% YoY), beating the $23.4M consensus, but posted a GAAP net loss of $1.1M vs net income of $1.1M a year ago. The company maintained its FY2026 revenue guidance of at least $100M and highlighted 36% HEPZATO volume growth and the CHOPIN trial publication in The Lancet Oncology as key catalysts.
Key Financial Metrics
Key Facts
- Q1 2026 total revenue of $25.0M, up 26% from $19.8M in Q1 2025
- GAAP net loss of $1.1M vs net income of $1.1M in Q1 2025
- GAAP diluted EPS of -$0.03 vs $0.03 in Q1 2025
- Non-GAAP adjusted EBITDA of $3.4M, down from $7.6M in Q1 2025
- FY2026 revenue guidance maintained at least $100M, gross margins 84%-87%
- HEPZATO volume grew ~36% YoY in Q1 2026; 29 active treatment centers
- CHOPIN Phase 2 trial results published in The Lancet Oncology
- Cash and investments of $89.3M, no debt as of March 31, 2026
- Repurchased 316,023 shares for ~$3.0M in Q1 2026 under $25M buyback program
Financial Impact
Revenue beat consensus by ~$1.6M (6.8%), but GAAP net income swung to a loss of $1.1M from a $1.1M profit a year ago. Adjusted EBITDA declined 55% to $3.4M.
Risk Factors
- GAAP net loss and declining adjusted EBITDA vs prior year
- FY2026 guidance of 'at least $100M' unchanged, no upward revision despite Q1 beat
- R&D expenses nearly doubled YoY to $9.8M, pressuring profitability
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-031725 |
| Document: dcth-20260507.htm | 0001628280-26-031725 |
| Document: 0001628280-26-031725-index-headers.html | 0001628280-26-031725 |
| Document: 0001628280-26-031725-index.html | 0001628280-26-031725 |
| Document: 0001628280-26-031725.txt | 0001628280-26-031725 |
| 8-K Data (Synthetic) | 0001628280-26-031725 |
Track record
12 reports on DCTH
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +27.22% at T+60 after the Feb 26, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago SC 13G/A Neutral 3/10 Entry $21.38 Now $19.87 −7.06% settles Feb 10
- Nov 9, 20267d ago 8-K Bullish 6/10 Entry $20.27 Now $19.87 −1.97% settles Feb 5
- Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $14.82 Now $19.87 +34.08% settles Feb 2
- Oct 27, 202620d ago SC 13G Neutral 3/10 Entry $14.86 Now $19.87 +33.71% settles Jan 26
- Oct 19, 202628d ago SC 13D/A Neutral 4/10 Entry $14.37 Now $19.87 +38.27% settles Jan 14
- Jun 11, 202622w ago Institutional Cluster Mixed 4/10 Entry $11.77 to $16.48 Now $19.87 +68.89% ▲ +40.08% +35.68% vs SPY
- May 14, 202626w ago 8-K Neutral 3/10 Entry $11.46 to $16.67 Now $19.87 +73.39% ▲ +45.46% +41.87% vs SPY
- May 7, 202627w ago 8-K Neutral 5/10 Viewing Entry $11.24 to $13.04 Now $19.87 +76.78% ▲ +16.01% +12.18% vs SPY
- Apr 2, 202632w ago DEFA14A Neutral 3/10 Entry $9.63 to $12.59 Now $19.87 +106.33% ▲ +30.74% +16.58% vs SPY
- Mar 2, 202637w ago Insider Cluster Bullish 6/10 Entry $8.93 to $10.83 Now $19.87 +122.51% ▲ +21.28% +11.95% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers